Sale!

TMEM240 Gene Spinocerebellar Ataxia Type 21 Autosomal Dominant Genetic Test

Original price was: $700.Current price is: $500.

-29%

The TMEM240 Gene Spinocerebellar Ataxia Type 21 Autosomal Dominant NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the TMEM240 gene responsible for Spinocerebellar Ataxia Type 21 (SCA21). This comprehensive test utilizes Next-Generation Sequencing technology to detect autosomal dominant genetic variations that cause progressive neurological disorders affecting coordination, balance, and motor function. The test is particularly valuable for individuals with family history of ataxia, unexplained coordination difficulties, or early-onset movement disorders. Results provide crucial information for accurate diagnosis, treatment planning, and genetic counseling. The test is available for $500 USD and offers a comprehensive analysis of the TMEM240 gene with results delivered within 3-4 weeks.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

TMEM240 Gene Spinocerebellar Ataxia Type 21 Autosomal Dominant NGS Genetic DNA Test

Comprehensive Genetic Testing for Neurological Disorders

The TMEM240 Gene Spinocerebellar Ataxia Type 21 Autosomal Dominant NGS Genetic DNA Test represents a significant advancement in neurological genetic diagnostics. This specialized test focuses on identifying mutations in the TMEM240 gene, which is directly associated with Spinocerebellar Ataxia Type 21 (SCA21), a rare autosomal dominant neurodegenerative disorder affecting the cerebellum and spinal cord.

What Does This Test Measure?

This comprehensive genetic analysis utilizes Next-Generation Sequencing (NGS) technology to thoroughly examine the TMEM240 gene for pathogenic variants. The test specifically detects:

  • Point mutations and single nucleotide variants in the TMEM240 gene
  • Small insertions and deletions affecting gene function
  • Autosomal dominant inheritance patterns
  • Genetic markers associated with progressive cerebellar degeneration
  • Specific mutations linked to early-onset ataxia symptoms

Who Should Consider This Test?

This genetic test is particularly recommended for individuals experiencing:

  • Progressive coordination difficulties and balance problems
  • Family history of spinocerebellar ataxia or similar neurological conditions
  • Early-onset movement disorders with unknown etiology
  • Unexplained gait abnormalities and speech difficulties
  • Cerebellar symptoms appearing in childhood or early adulthood
  • Individuals with affected family members seeking genetic confirmation

Clinical Benefits of Testing

Undergoing the TMEM240 gene test provides numerous clinical advantages:

  • Accurate diagnosis and differentiation from other ataxia types
  • Early intervention and treatment planning opportunities
  • Comprehensive genetic counseling for family planning
  • Clear understanding of inheritance patterns and risk assessment
  • Personalized management strategies for symptom progression
  • Access to specialized neurological care and support services

Understanding Your Test Results

Your genetic test results will be thoroughly explained by our certified genetic counselors:

  • Positive Result: Indicates the presence of a pathogenic TMEM240 mutation, confirming SCA21 diagnosis
  • Negative Result: Suggests absence of known TMEM240 mutations, though other genetic causes may need investigation
  • Variant of Uncertain Significance: Requires additional family studies and clinical correlation
  • Carrier Status: Important information for family planning and genetic counseling

Test Pricing Information

Test Description Price (USD)
TMEM240 Gene Spinocerebellar Ataxia Type 21 Autosomal Dominant NGS Genetic DNA Test Discount Price: $500
Regular Price: $700

Test Specifications

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Methodology: Next-Generation Sequencing (NGS) Technology
  • Specialty: Neurology and Genetics
  • Disease Focus: Neurological Disorders

Pre-Test Requirements

Before scheduling your test, please ensure:

  • Complete clinical history documentation
  • Genetic counseling session to create detailed family pedigree
  • Discussion of testing implications with healthcare provider
  • Understanding of potential outcomes and their significance

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and neurological specialists ensures comprehensive care regardless of your location.

Take Control of Your Neurological Health Today

Don’t let uncertainty about neurological symptoms affect your quality of life. The TMEM240 Gene Spinocerebellar Ataxia Type 21 test provides definitive answers and empowers you with knowledge for better health management. Our team of genetic specialists and neurologists are ready to support you through every step of the testing process.

Call or WhatsApp us now at +1(267) 388-9828 to schedule your genetic counseling session and book your TMEM240 gene test. Take the first step toward accurate diagnosis and personalized care.